Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis Isla S. MackenzieLi WeiThomas M. MacDonald Review Article Open access 26 June 2012 Pages: 133 - 141
Pharmacokinetics of transdermal buprenorphine patch in the elderly Nabil Al-TawilIngegerd Odar-CederlöfJan Persson Clinical Trial Open access 17 June 2012 Pages: 143 - 149
Chemotherapy plus multitargeted antiangiogenic tyrosine kinase inhibitors or chemotherapy alone in advanced NSCLC: a meta-analysis of randomized controlled trials Yong-Ying XiaoPing ZhanYi Shi Clinical Trial 24 June 2012 Pages: 151 - 159
Evaluating the effects of diclofenac sodium and etodolac on renal hemodynamics with contrast-enhanced ultrasonography: a pilot study Hiroshi ImamuraJiro HataKen Haruma Clinical Trial 26 June 2012 Pages: 161 - 165
eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril P. S. SilvaV. FontanaJ. E. Tanus-Santos Pharmacogenetics 17 June 2012 Pages: 167 - 177
Drug–drug interaction of rabeprazole and clopidogrel in healthy Chinese volunteers Jia WuLi-Tao JiaJian-Ting Cai Pharmacogenetics 16 June 2012 Pages: 179 - 187
Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients Wei ZhaoMay FakhouryEvelyne Jacqz-Aigrain Pharmacogenetics 17 June 2012 Pages: 189 - 195
High inter-individual variability of vardenafil pharmacokinetics in patients with pulmonary hypertension A. M. SandqvistD. HenrohnB. G. Wikström Pharmacokinetics and Disposition 26 June 2012 Pages: 197 - 207
Intensive monitoring of duloxetine: results of a web-based intensive monitoring study Linda HärmarkEugène van PuijenbroekKees van Grootheest Pharmacoepidemiology and Prescription Open access 12 June 2012 Pages: 209 - 215
The role of Periodic Safety Update Reports in the safety management of biopharmaceuticals Hans C. EbbersAukje K. Mantel-TeeuwisseHubert G. M. Leufkens Pharmacoepidemiology and Prescription Open access 17 June 2012 Pages: 217 - 226
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care Gianluca TrifiròSilvia TillatiFabio Samani Pharmacoepidemiology and Prescription 17 June 2012 Pages: 227 - 236
Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia–Romagna region) Chiara BiagiNicola MontanaroDomenico Motola Pharmacoepidemiology and Prescription 17 June 2012 Pages: 237 - 244
Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors’ adherence to warfarin therapy recommendations Axel C. CarlssonPer WändellJan Sundquist Pharmacoepidemiology and Prescription 10 June 2012 Pages: 245 - 253
Improvement in the detection of adverse drug events by the use of electronic health and prescription records: An evaluation of two trigger tools Ugochi NwuluKrishnarajah NirantharakumarJamie J. Coleman Pharmacoepidemiology and Prescription 17 June 2012 Pages: 255 - 259
Statin use among older Finns stratified according to cardiovascular risk Eveliina UpmeierMaarit Jaana KorhonenRisto Huupponen Pharmacoepidemiology and Prescription 17 June 2012 Pages: 261 - 267
Safety of ginger use in pregnancy: results from a large population-based cohort study Kristine HeitmannHedvig NordengLone Holst Pharmacoepidemiology and Prescription 17 June 2012 Pages: 269 - 277
Effect of cardiovascular drug classes on all-cause mortality among atrial fibrillation patients treated in primary care in Sweden: a cohort study Per WändellAxel C. CarlssonJan Sundquist Pharmacoepidemiology and Prescription 19 September 2012 Pages: 279 - 287
Case series: paradoxical action of domperidone leads to increased vomiting Marco PozziSandra StrazzerSonia Radice Letter to the Editors 16 June 2012 Pages: 289 - 290
Administration of tramadol or ibuprofen increases the INR level in patients on warfarin Jacob JuelTorben Brøchner PedersenSvend Eggert Jensen Letter to the Editors 17 June 2012 Pages: 291 - 292
Delayed warfarin induced skin necrosis in a patient with poor warfarin metabolizing activity due to interrupted warfarin therapy Tejasvita GaikwadKanjaksha GhoshShrimati Shetty Letter to the Editors 17 June 2012 Pages: 293 - 294